CytoSorbents Corporation (CTSO)

[lexusandolive]

Through deductive reasoning Cytosorb should have big numbers in it's report tomorrow??

Cytosorb on Oct 5th said they had over 8,000 treatments. On August 13th, their last quarterly report said they had over 6,000 treatments. I don't know exactly when those sales will post, some payments may fall into next quarter, but even with some give and take, this quarter should far exceed any previous quarter in terms of sales.

The reason I say that is it took them 12 quarters to reach over 6,000 (6,000 - 6,300) treatments totaling $5,535,583 at an average cost per treatment of $900, and now in less than two months they report 2,000 more treatments, that would give them $1,800,000 of product sales less than 2/3 of the way into the quarter. The product sales of the last 10 quarters starting from Q1 2013 were: $176,098; $127,969; $203,561; $314,159; $569,243; $663,233; $1,031,761; $871,150; $703,658; $773,112.

Based on the information reported by Cytosorb Q3 should be in the range of $1,800,000 - $2,700,000

(Adjusted for the Euro it would still be about double Q2 2015 product sales.)

Biotech has been beaten up lately and CTSO less so, but still valued at less than it should be.

Based on this chart from the August 13 Q2 presentation, page 10
http://www.cytosorbents.com/pdf/CTSO_Q2_2015_Earnings_Presentation.pdf
And this press release emailed Oct 5th (which curiously is not listed on their media sites yet) "CytoSorbents Reports CytoSorb® Usage Grows to 8,000+ Human Treatments at Successful Second International Users Meeting"